文献速递贫血与红细胞疾病血栓与止血

遗传性出血性毛细血管扩张症可能是女性中最严重的遗传性出血性疾病

Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women.
PubMed 文献 · Blood Adv · 2024-01-01

该观察性队列研究将100例随机选取的遗传性出血性毛细血管扩张症(HHT)女性与100例年龄匹配的血管性血友病(VWD)女性进行比较,发现HHT患者的反复鼻衄、消化道出血、缺铁性贫血、铁剂输注依赖、红细胞输注、止血手术及住院频率均显著更高,而重度月经出血更少,提示HHT可能是女性中最具临床意义的遗传性出血性疾病。

要点

  • HHT女性反复鼻衄和消化道出血的OR分别为32.73和5.69,均显著高于VWD女性。
  • HHT女性重度月经出血的OR为0.32,显著低于VWD女性。
  • HHT女性铁剂输注依赖、红细胞输注和止血手术的 odds 分别约为VWD女性的17倍、3倍和8倍。

核心结论

  • HHT女性较VWD女性表现出更高的疾病相关发病率、死亡率和医疗资源使用,提示HHT可能是女性中最具临床意义的遗传性出血性疾病。

研究设计与样本

  • 观察性队列研究,比较100例随机选取的HHT女性与100例随机选取的年龄匹配的VWD女性。

主要发现

  • HHT vs VWD中,反复鼻衄更可能发生(OR 32.73,95%CI 13.81-71.80;P < .0001),消化道出血更可能发生(OR 5.69,95%CI 2.59-12.89;P < .0001),重度月经出血更不可能发生(OR 0.32,95%CI 0.18-0.57;P < .0001)。
  • HHT女性缺铁性贫血显著更可能发生,且最低血红蛋白显著低于VWD女性。
  • HHT女性铁剂输注依赖、红细胞输注需求和止血手术的 odds 分别约为VWD女性的17倍、3倍和8倍。
  • HHT女性因疾病并发症住院的频率约为VWD女性的14倍。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hereditary hemorrhagic telangiectasia (HHT) is the second-most common inherited bleeding disorder (BD) worldwide and remains without approved therapies. HHT causes serious mucosal bleeding resulting in severe iron-deficiency anemia, major psychosocial complications, and visceral arteriovenous malformations in the brain, lung, and liver, which can cause life-threatening hemorrhagic complications. No study has examined the relative morbidity of HHT and von Willebrand disease (VWD), which is the most common inherited BD in women. We performed an observational cohort study of women with HHT or VWD, comparing a representative sample of 100 randomly selected women with HHT to 100 randomly selected age-matched women with VWD. In HHT vs VWD, recurrent epistaxis and gastrointestinal bleeding were more likely (odds ratio [OR], 32.73 [95% confidence interval, 13.81-71.80]; P < .0001 and 5.69 [2.59-12.89]; P < .0001) and heavy menstrual bleeding was less likely (OR, 0.32 [0.18-0.57]; P < .0001). Iron-deficiency anemia was significantly more likely, and the lowest hemoglobin was significantly lower in HHT than in VWD. The odds of iron infusion dependence, requirement for red cell transfusion, and hemostatic surgical procedures were significantly higher-17-fold, threefold, and eightfold higher, respectively-and hospital admissions to manage disease complications were both ∼14 times more frequent in women with HHT vs those with VWD. In conclusion, much higher disease-related morbidity, mortality, and health care use were observed in women with HHT vs VWD, providing evidence that HHT may be the most clinically significant inherited BD in women. Given the vast gap in research funding for HHT compared with both hemophilia (a disease primarily of men) and VWD, these findings have significant implications for gender equity in hematology.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Zhang E, Virk ZM, Rodriguez-Lopez J, et al. Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood Adv. 2024. PMID: 38593443. doi:10.1182/bloodadvances.2023011961

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。